Juan Blanco Morillo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Haemo-autologous Antegrade Repriming (HAR) as Minimum Impact Perfusion Strategy for Cardiopulmonary Bypass (NCT03720184) | Juan Blanco Morillo | 2018-08-15 |
Track Juan Blanco Morillo automatically
Every clearance here is in the API, with alerts when new ones post.